Related Experiment Video
Updated: Aug 11, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI
Jonathan M Schott1, Jessica E Simon, Nick C Fox
1Dementia Research Group, Institute of Neurology, London, United Kingdom.
Abstract:
We describe the pattern and progression of atrophy delineated using fluid registration of serial magnetic resonance imaging scans in a case of multiple system atrophy (MSA). The in vivo findings were consistent with those found at postmortem, including significant supratentorial atrophy concurrent with an unusual degree of cognitive impairment for MSA.
Insights
This study tracked brain atrophy in multiple system atrophy (MSA) using MRI scans. Findings revealed significant brain atrophy and unexpected cognitive decline in the patient.
Area of Science:
- Neuroimaging
- Neuropathology
- Clinical Neurology
Background:
- Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
- Understanding the in vivo progression of brain atrophy in MSA is crucial for diagnosis and treatment.
- Serial magnetic resonance imaging (MRI) offers a non-invasive method to study neurodegenerative changes.
Observation:
- The study utilized fluid registration of serial MRI scans to precisely map brain atrophy.
- The progression of atrophy was observed over time in a single case of MSA.
- In vivo imaging findings were correlated with established postmortem neuropathological data.
Findings:
- Significant supratentorial atrophy was detected in the patient.
- The observed atrophy pattern aligns with known neuropathological features of MSA.
- An unusual degree of cognitive impairment was noted, which is atypical for the typical presentation of MSA.
Implications:
- This case highlights the utility of advanced MRI techniques in characterizing MSA progression.
- The findings suggest a potential link between specific patterns of atrophy and cognitive deficits in MSA.
- Further research with larger cohorts is warranted to validate these observations and explore therapeutic strategies.

